Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Karolina Matyjaszczyk‐Gwarda"'
Autor:
Anna Bar, Anna Kieronska‐Rudek, Bartosz Proniewski, Joanna Suraj‐Prażmowska, Krzysztof Czamara, Brygida Marczyk, Karolina Matyjaszczyk‐Gwarda, Agnieszka Jasztal, Edyta Kuś, Zuzanna Majka, Agnieszka Kaczor, Anna Kurpińska, Maria Walczak, Elsbet J. Pieterman, Hans M. G. Princen, Stefan Chlopicki
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 21 (2020)
Background Long‐term feeding with a high‐fat diet (HFD) induces endothelial dysfunction in mice, but early HFD‐induced effects on endothelium have not been well characterized. Methods and Results Using an magnetic resonance imaging‐based meth
Externí odkaz:
https://doaj.org/article/5a0b10f5489c43d78e0de55a19f9de98
Autor:
Marta Smeda, Agnieszka Kij, Bartosz Proniewski, Karolina Matyjaszczyk-Gwarda, Kamil Przyborowski, Agnieszka Jasztal, Katarzyna Derszniak, Piotr Berkowicz, Anna Kieronska-Rudek, Marta Stojak, Magdalena Sternak, Stefan Chlopicki
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0230520 (2020)
Long-term administration of acetylsalicylic acid (ASA) was effective in prevention of colorectal cancer, whereas the efficacy of this compound in other cancer types, including breast cancer, has been less convincingly documented. Indeed, the antimeta
Externí odkaz:
https://doaj.org/article/55ce6137b7104fe780b7a46b7081604a
Autor:
Bartosz Proniewski, Anna Bar, Anna Kieronska-Rudek, Joanna Suraj-Prażmowska, Elżbieta Buczek, Krzysztof Czamara, Zuzanna Majka, Izabela Czyzynska-Cichon, Grzegorz Kwiatkowski, Karolina Matyjaszczyk-Gwarda, Stefan Chlopicki
Publikováno v:
Cells, Vol 10, Iss 6, p 1448 (2021)
Hyperglycemia linked to diabetes results in endothelial dysfunction. In the present work, we comprehensively characterized effects of short-term hyperglycemia induced by administration of an insulin receptor antagonist, the S961 peptide, on endotheli
Externí odkaz:
https://doaj.org/article/1517ebfc9ab34da580349e41ee964cdd
Autor:
Karolina Matyjaszczyk-Gwarda, Mariola Olkowicz, Maria Walczak, Stefan Chlopicki, Benedikt Fels, Agnieszka Kij, Kristina Kusche-Vihrog
Publikováno v:
Talanta. 238(Pt 1)
Glycosaminoglycans (GAGs) constitute the main building blocks of the endothelial glycocalyx (GLX), and disruption of GLX initiates and promotes endothelial dysfunction. Here, we aimed to develop a novel, specific and accurate LC-SRM/MS-based method f
Autor:
Karolina Matyjaszczyk-Gwarda, Joanna Suraj-Prazmowska, Bartosz Proniewski, Stefan Chlopicki, Zuzanna Majka, Grzegorz Kwiatkowski, Anna Bar, Elzbieta Buczek, Izabela Czyzynska-Cichon, Anna Kieronska-Rudek, Krzysztof Czamara
Publikováno v:
Cells
Volume 10
Issue 6
Cells, Vol 10, Iss 1448, p 1448 (2021)
Volume 10
Issue 6
Cells, Vol 10, Iss 1448, p 1448 (2021)
Hyperglycemia linked to diabetes results in endothelial dysfunction. In the present work, we comprehensively characterized effects of short-term hyperglycemia induced by administration of an insulin receptor antagonist, the S961 peptide, on endotheli
Autor:
Brygida Marczyk, Stefan Chlopicki, Agnieszka Jasztal, Anna Bar, Hans M.G. Princen, Anna Kurpińska, Karolina Matyjaszczyk-Gwarda, Elsbet J. Pieterman, Agnieszka Kaczor, Joanna Suraj-Prazmowska, Bartosz Proniewski, Maria Walczak, Zuzanna Majka, Edyta Kuś, Krzysztof Czamara, Anna Kieronska-Rudek
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Long‐term feeding with a high‐fat diet (HFD) induces endothelial dysfunction in mice, but early HFD‐induced effects on endothelium have not been well characterized. Methods and Results Using an magnetic resonance imaging‐based meth
Autor:
Małgorzata Łukawska, Stefan Chlopicki, Tomasz Wojcik, Karolina Matyjaszczyk-Gwarda, Maria Walczak
Publikováno v:
Electrophoresis6 References. 40(23-24)
Accurate profiling of the lipophilicity of amphoteric compounds might be complex and laborious. In the present work the lipophilicity of 12 anthracycline antibiotics-four parent drugs: doxorubicin, daunorubicin, epidoxorubicin, and epidaunorubicin an